Similar Papers

Paper Title
Journal
Date
Author
Identifying a potential biomarker for anti-PD-1 immunotherapy in patients with advanced stage, surgically-resectable endometrial cancer.
Katherine Cynthia Fuh ... Wendy Fantl
Journal of Clinical Oncology | VOL. 37
Katherine Cynthia Fuh, et. al.Katherine Cynthia Fuh ... Wendy Fantl
20 May 2019
Abstract PR004: Multi-dimensional biomarker analyses identify pembrolizumab responders in advanced stage, high grade endometrial cancer
Katherine Fuh ... Matthew Powell
Clinical Cancer Research | VOL. 27
Katherine Fuh, et. al.Katherine Fuh ... Matthew Powell
01 Feb 2021
Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI.
Chia-Ni Lin ... Yue-Sheng Wang
PloS one | VOL. 11
Chia-Ni Lin, et. al.Chia-Ni Lin ... Yue-Sheng Wang
21 Jun 2016
Abstract IA004: Universal tumor screening for Lynch syndrome versus germline multi-gene panel testing for all endometrial cancer patients
Heather Hampel
Clinical Cancer Research | VOL. 30
Heather HampelHeather Hampel
01 Mar 2024
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
Editorial Board
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
89P Spatial analysis using MultiOmyx hyperplex assay reveals high prevalence of mature tertiary lymphoid structure (TLS) and PDL1 expression in the MSI-high colorectal carcinoma (CRC)
Q Au ... V Chizhevsky
Annals of Oncology | VOL. 35
Q Au, et. al.Q Au ... V Chizhevsky
01 Dec 2024
276MO Epidemiology, treatment (tx) patterns, and clinical outcomes of patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) in Taiwan: A retrospective cohort study
C-T Wu ... L-N Chien
Annals of Oncology | VOL. 35
C-T Wu, et. al.C-T Wu ... L-N Chien
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.